Literature DB >> 6777664

Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.

R Cherniak, E Reiss, M E Slodki, R D Plattner, S O Blumer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6777664     DOI： 10.1016/0161-5890(80)90096-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN： 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  64 in total

1.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.

Authors:  Marcellene A Gates-Hollingsworth; Thomas R Kozel
Journal:  Mol Microbiol       Date:  2009-09-02       Impact factor: 3.501

4.  Taxonomic studies on Filobasidiella species and their anamorphs.

Authors:  K J Kwon-Chung; J E Bennett; J C Rhodes
Journal:  Antonie Van Leeuwenhoek       Date:  1982       Impact factor: 2.271

5.  A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.

Authors:  M Piccioni; C Monari; S Kenno; E Pericolini; E Gabrielli; D Pietrella; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

6.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.

Authors:  T Belay; R Cherniak; T Shinoda
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.

Authors:  J M Small; T G Mitchell; R W Wheat
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

10.  Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.

Authors:  J M Small; T G Mitchell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.